TRT coaching claims on TikTok: what the evidence actually says

What did @coachbraedenmiller actually say?

The creator laid out a full TRT protocol framework in under a minute. The core claims: starting doses should sit between "150 to 250" mg because the goal is optimization, not just hitting normal range. Injections should happen daily for stable levels. Blood work quarterly. Aromatase inhibitors are unnecessary and prescribing them makes you "stupid." HCG is optional unless fertility matters. And the big critique, clinics prescribing once every two weeks are causing "massive peaks, massive valleys" that destabilize mood and libido.

That is a lot of clinical opinion packed into a short video, and some of it holds up better than others. The frequency argument is grounded in pharmacokinetics. The dose range claim is where things get more complicated, and the AI dismissal, while common in optimization circles, is stated with more certainty than the evidence warrants.

Does the science back this up?

The injection frequency argument is the strongest claim here. Pharmacokinetic data on testosterone cypionate and enanthate consistently shows that more frequent, smaller injections reduce peak-to-trough variation. That part is well-supported.

Testosterone cypionate has a half-life of roughly 8 days, meaning a weekly injection still produces meaningful fluctuation over 7 days. A 2020 study by Ramasamy et al. in The Journal of Urology confirmed that subcutaneous testosterone cypionate administered in smaller, more frequent doses produced more stable serum levels with fewer side effects than traditional intramuscular protocols. Daily microdosing takes this further, and while clinical trial data on daily subcutaneous dosing is thinner, the pharmacokinetic logic is sound.

The dose range of 150-250mg per week is where the science gets murkier. Standard hypogonadism treatment guidelines from the American Urological Association and Endocrine Society target total testosterone in the 400-700 ng/dL range, not a specific mg dose. Individual response varies considerably based on SHBG, hematocrit, and metabolism. A 150mg weekly dose might be appropriate for one patient and supraphysiologic for another.

On aromatase inhibitors: the claim that no one should need them is overstated. Research by Shoskes et al. (2016, Translational Andrology and Urology) found that a subset of TRT patients, particularly those with higher body fat or genetic variants in aromatase expression, do experience symptomatic estrogen excess that responds to AI treatment. Blanket dismissal ignores that subset.

What did they get wrong (or right)?

Credit where it is due: the criticism of biweekly injections is correct and clinically important. Testosterone cypionate dosed once every two weeks creates extreme serum fluctuations. Patients often feel good for days 3-7 and then crash before their next injection. This is a known problem. Guidelines have moved away from biweekly dosing precisely because of this. The creator is right to call it out.

The quarterly blood work recommendation is reasonable as a maintenance goal, though most endocrinologists recommend more frequent monitoring during the first 6-12 months of therapy, typically every 3 months initially, then annually once stable, per Endocrine Society 2018 guidelines.

The dose range of 150-250mg framed as a starting point for "optimization" is the most problematic part of this video. That upper end approaches doses used in performance-enhancement contexts, not standard hypogonadism treatment. Presenting this as a starting range without discussing individual labs, SHBG levels, or hematocrit risk is irresponsible framing for a general audience.

The AI dismissal is stated too absolutely. Some patients do need them. Calling any prescriber "stupid" for using them ignores legitimate clinical scenarios where estrogen management is appropriate and evidence-based.

What should you actually know?

TRT is not a one-size protocol. The right dose is the dose that gets your testosterone into a therapeutic range based on your labs, symptoms, and clinical history, not a predetermined milligram target. Anyone setting a floor of 150mg or a ceiling of 250mg as a "starting" range without reviewing your bloodwork is working backwards.

Injection frequency is a real clinical variable. If you are on weekly injections and experiencing mood swings, energy crashes, or libido fluctuations mid-cycle, more frequent dosing is a legitimate conversation to have with your prescriber. The pharmacokinetics support it.

Aromatase inhibitors are not automatically bad. They are also not automatically necessary. Estradiol should be monitored on TRT, and if symptomatic elevation occurs and lifestyle factors do not resolve it, an AI may be clinically appropriate. The decision should be based on labs and symptoms, not ideology.

HCG for fertility preservation is a reasonable addition if maintaining testicular function or sperm production matters to you. TRT alone suppresses LH and FSH, which reduces intratesticular testosterone and can impair spermatogenesis. That is a real tradeoff worth discussing with your doctor before starting.